Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.401
+0.001 (0.03%)
Sep 15, 2025, 9:37 AM EDT - Market open
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $16.90 million as of September 15, 2025. Its market cap has increased by 10.43% in one year.
Market Cap
16.90M
Enterprise Value
4.53M
1-Year Change
10.43%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since November 5, 2015, Edesa Biotech's market cap has decreased from $74.90M to $16.90M, a decrease of -77.44%. That is a compound annual growth rate of -14.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 16.90M | 191.38% |
| Dec 31, 2024 | 5.80M | -60.00% |
| Dec 29, 2023 | 14.50M | -65.31% |
| Dec 30, 2022 | 41.80M | -45.07% |
| Dec 31, 2021 | 76.10M | 70.25% |
| Dec 31, 2020 | 44.70M | 45.13% |
| Dec 31, 2019 | 30.80M | 528.57% |
| Dec 31, 2018 | 4.90M | -42.35% |
| Dec 29, 2017 | 8.50M | -58.74% |
| Dec 30, 2016 | 20.60M | -62.34% |
| Dec 31, 2015 | 54.70M | -26.97% |
| Nov 5, 2015 | 74.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |